Alerts

Recall - risk of plastic fragments breaking from bottle and being ingested

Update - recall - additional batch affected

Recall - potential for particle contamination

Hazard alert - higher than expected revision rates

Recall – potential for contamination with latex

Hazard alert update - additional issue that can result in an unintended device software reset

Hazard alert - potential for component failure due to metal fracture

Hazard alert - risk of implant breakage that could cause adverse events and require additional surgery

Update - recall - additional batches affected

Recall - risk of plastic fragments breaking from bottle and being ingested

Hazard alert - warnings regarding potential adverse events

Recall for product correction - potential for interruption of medicine delivery and/or infection due to needle breaking during use

Recall for product correction - potential for interruption of insulin delivery and/or infection due to needle breaking during use

Recall for product correction - increased risk of death for patients with symptomatic chronic heart failure

Multiple devices which use auto servo ventilation/Adaptive Servo-Ventilation (ASV) therapy have been subject to recall actions

Recall for product correction - additional affected devices

Recall - pumps will cease operation on 1 January 2016

Recall - risk of adverse events due to unacceptably high level of arsenic

Hazard alert - multiple potential safety issues

Recall for product correction - fire risk from faulty component

Recall for product correction - fire risk from faulty component

The following medicines (with brand names in brackets) should be returned to a pharmacy: alprazolam (Xanax), cabergoline (Dostinex and Cabaser), mefanamic acid (Ponstan), methotrexate (Methoblastin) and triazolam (Halcion)

Recall - bottles supplied without child-resistant caps

Recall for product correction - risk of sparking or fire due to damaged or cut wire

Recall - counterfeit products may have defects and not be effective